DiviDrip · RLYB

RLYB — Rallybio Corporation

RLYB is Rallybio Corporation (Healthcare) — a non-dividend-paying stock. Trading at $16.89. Market cap: $90M. Capital Quality Rank: 52/100 — Above average.

Stock snapshot

Price$16.89
Market cap$90M
SectorHealthcare
ExchangeNCM
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)52 / 100 · Above average
ROIC (TTM)-40.0%
Shareholder buyback yield-3.30%
Altman Z-score zoneSafe

About RLYB

Rallybio Corp is a clinical-stage biotechnology company comprised of experienced biopharma industry leaders with extensive research, development, and rare disease expertise with a mission to develop and commercialize life-transforming therapies for patients with severe and rare diseases. The company's program, RLYB116, is a differentiated complement component 5 (C5) inhibitor with the potential to treat diseases of complement dysregulation. The Company manages its operations as a single segment for the purposes of allocating resources, assessing performance, and making operating decisions. Rallybio's pipeline also includes RLYB332, a preclinical long-acting matriptase-2 antibody for the treatment of diseases of iron overload.

Listed2021Employees7HQNew Haven, CTSectorHealthcareWebsiterallybio.com

Related non-dividend companies

Other non-dividend stocks investors research alongside RLYB. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is RLYB's current stock price?

RLYB (Rallybio Corporation) is currently trading at $16.89.

Does RLYB pay a dividend?

RLYB (Rallybio Corporation) does not currently pay a regular dividend.

What is RLYB's Capital Quality Rank?

RLYB has a Capital Quality Rank of 52/100 — Above average. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track RLYB in DiviDrip

Add RLYB to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-03. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow